DE69013607T2 - Pyrazol-Derivate, Verfahren zu deren Herstellung und Anwendung. - Google Patents

Pyrazol-Derivate, Verfahren zu deren Herstellung und Anwendung.

Info

Publication number
DE69013607T2
DE69013607T2 DE69013607T DE69013607T DE69013607T2 DE 69013607 T2 DE69013607 T2 DE 69013607T2 DE 69013607 T DE69013607 T DE 69013607T DE 69013607 T DE69013607 T DE 69013607T DE 69013607 T2 DE69013607 T2 DE 69013607T2
Authority
DE
Germany
Prior art keywords
pyrazole derivatives
preparation
group
angiotensin
therapeutics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69013607T
Other languages
English (en)
Other versions
DE69013607D1 (de
Inventor
Takehiko Naka
Kohei Nishikawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of DE69013607D1 publication Critical patent/DE69013607D1/de
Application granted granted Critical
Publication of DE69013607T2 publication Critical patent/DE69013607T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
DE69013607T 1989-08-02 1990-07-27 Pyrazol-Derivate, Verfahren zu deren Herstellung und Anwendung. Expired - Fee Related DE69013607T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP20096389 1989-08-02
JP23512489 1989-09-11
JP29345989 1989-11-10

Publications (2)

Publication Number Publication Date
DE69013607D1 DE69013607D1 (de) 1994-12-01
DE69013607T2 true DE69013607T2 (de) 1995-03-02

Family

ID=27327884

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69013607T Expired - Fee Related DE69013607T2 (de) 1989-08-02 1990-07-27 Pyrazol-Derivate, Verfahren zu deren Herstellung und Anwendung.

Country Status (5)

Country Link
US (1) US5183899A (de)
EP (1) EP0411507B1 (de)
AT (1) ATE113281T1 (de)
CA (1) CA2022419A1 (de)
DE (1) DE69013607T2 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122010000024I1 (de) * 1990-02-19 2010-07-08 Novartis Ag Acylverbindungen
IE910913A1 (en) * 1990-03-20 1991-09-25 Sanofi Sa N-substituted heterocyclic derivates, their preparation¹and pharmaceutical compositions containing them
AU636066B2 (en) * 1990-10-30 1993-04-08 Takeda Chemical Industries Ltd. Thienoimidazole derivatives, their production and use
FR2672891B1 (fr) * 1991-02-20 1994-02-18 Synthelabo Derives de 3-pyrazolones, leur preparation et leur application en therapeutique.
US5164403A (en) * 1991-04-05 1992-11-17 G. D. Searle & Co. N-arylheteroarylalkyl imidazol-2-one compounds for treatment of circulatory disorders
TW274551B (de) * 1991-04-16 1996-04-21 Takeda Pharm Industry Co Ltd
IL102183A (en) * 1991-06-27 1999-11-30 Takeda Chemical Industries Ltd The heterocyclic compounds are converted into biphenyl groups, their production and the pharmaceutical compositions containing them
DK0528762T3 (da) * 1991-08-15 1997-08-25 Ciba Geigy Ag N-acyl-N-heterocyclyl- eller naphthylalkyl-aminosyrer som angiotensin II antagonister
AT398202B (de) * 1991-10-04 1994-10-25 Chem Pharm Forsch Gmbh Neue imidazolderivate, verfahren zu ihrer herstellung und ihre verwendung
US5256654A (en) * 1991-10-24 1993-10-26 American Home Products Corporation Substituted pyrrolopyrimidines, azepinopyrimidines and pyridopyrimidines useful as angiotensin II antagonists
US5149699A (en) * 1991-10-24 1992-09-22 American Home Products Corporation Substituted pyridopyrimidines useful as antgiotensin II antagonists
TW284688B (de) * 1991-11-20 1996-09-01 Takeda Pharm Industry Co Ltd
CA2115985A1 (en) * 1993-02-25 1994-08-26 Kohei Nishikawa Vascular hypertrophy suppressor
JP3810020B2 (ja) * 1993-04-22 2006-08-16 武田薬品工業株式会社 腎疾患の予防または治療剤
US5721263A (en) 1993-06-07 1998-02-24 Takeda Chemical Industries, Ltd. Pharmaceutical composition for angiotensin II-mediated diseases
CZ154994A3 (en) * 1993-07-02 1995-09-13 Senju Pharma Co Visual hypotensive agent
AU2745199A (en) 1998-03-04 1999-09-20 Takeda Chemical Industries Ltd. Sustained-release preparation for aii antagonist, production and use thereof
SE9903028D0 (sv) 1999-08-27 1999-08-27 Astra Ab New use
TWI243164B (en) 2001-02-13 2005-11-11 Aventis Pharma Gmbh Acylated indanyl amines and their use as pharmaceuticals
US7812044B2 (en) 2001-11-13 2010-10-12 Takeda Pharmaceutical Company Limited Anticancer agents
US7803940B2 (en) * 2006-11-24 2010-09-28 Takeda Pharmaceutical Company Limited Heteromonocyclic compound or a salt thereof having strong antihypertensive action, insulin sensitizing activity and the like production thereof and use thereof for prophylaxis or treatment of cardiovascular diseases, metabolic diseases and/or central nervous system diseases
EA200970510A1 (ru) * 2006-11-24 2009-12-30 Такеда Фармасьютикал Компани Лимитед Гетеромоноциклическое соединение и его применение
TWI448284B (zh) * 2007-04-24 2014-08-11 Theravance Inc 雙效抗高血壓劑
US20080293644A1 (en) * 2007-04-27 2008-11-27 Thomas Eidenberger Guava extract
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EA020466B1 (ru) 2007-06-04 2014-11-28 Синерджи Фармасьютикалз Инк. Агонисты гуанилатциклазы, пригодные для лечения желудочно-кишечных нарушений, воспаления, рака и других заболеваний
WO2009007399A1 (en) * 2007-07-12 2009-01-15 Crystax Pharmaceuticals, S.L. New compounds as hsp90 inhibitors
JP2011522828A (ja) 2008-06-04 2011-08-04 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
CA2730603C (en) 2008-07-16 2019-09-24 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2010011821A2 (en) * 2008-07-24 2010-01-28 Theravance, Inc. Dual-acting antihypertensive agents
WO2011005674A1 (en) 2009-07-07 2011-01-13 Theravance, Inc. Dual-acting pyrazole antihypertensive agents
EP2456762B1 (de) 2009-07-22 2013-10-16 Theravance, Inc. Blutdrucksenkende oxazolmittel mit doppelwirkung
EP2526095A1 (de) 2010-01-19 2012-11-28 Theravance, Inc. Doppelt wirkende blutdrucksenkende thiophen-, pyrrol-, thiazol- und furan-mittel
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
JP2016514670A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
AU2014235215A1 (en) 2013-03-15 2015-10-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
KR102272746B1 (ko) 2013-06-05 2021-07-08 보슈 헬스 아일랜드 리미티드 구아닐레이트 사이클라제 c의 초순수 작용제, 및 이의 제조 및 사용 방법
WO2018200674A1 (en) * 2017-04-26 2018-11-01 Mitobridge, Inc. Dynamin-1-like protein inhibitors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5671073A (en) * 1979-11-12 1981-06-13 Takeda Chem Ind Ltd Imidazole derivative
JPS5671074A (en) * 1979-11-12 1981-06-13 Takeda Chem Ind Ltd 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative
US4812462A (en) * 1986-04-01 1989-03-14 Warner-Lambert Company 4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid analogs having antihypertensive activity
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
US4820843A (en) * 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
US4880804A (en) * 1988-01-07 1989-11-14 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking benzimidazoles
US5015651A (en) * 1988-01-07 1991-05-14 E. I. Du Pont De Nemours And Company Treatment of hypertension with 1,2,4-angiotensin II antagonists

Also Published As

Publication number Publication date
EP0411507B1 (de) 1994-10-26
DE69013607D1 (de) 1994-12-01
US5183899A (en) 1993-02-02
CA2022419A1 (en) 1991-02-03
EP0411507A1 (de) 1991-02-06
ATE113281T1 (de) 1994-11-15

Similar Documents

Publication Publication Date Title
DE69013607D1 (de) Pyrazol-Derivate, Verfahren zu deren Herstellung und Anwendung.
DE69021502D1 (de) Benzimidazolderivate, Verfahren zu deren Herstellung und Anwendung.
DE69534029D1 (de) Herstellung von Camptothecinderivaten durch intramolekulare Cyclisierung
DE69029334D1 (de) Verfahren zur Herstellung von Alkoxyiminoacetamid-Derivaten und ein Zwischenproduckt dafür
ATE126216T1 (de) Pyrazolderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellung.
ATE90676T1 (de) Dioxyalkylenaryl-dihydropyridine zwischenprodukte zu ihrer herstellung, verfahren zu ihrer herstellung und ihre verwendung.
AT389108B (de) Neue pyridazinonderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
ATE67199T1 (de) Benzoxazin-derivate und verfahren zu ihrer herstellung.
EP0242070A3 (de) Phenylacrylsäureester-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Fungizide
ATE115567T1 (de) Verfahren zur herstellung von halogensulfonyl- substituierten pyridinen.
DE59905700D1 (de) N-phenylacetoacetamide und Verfahren zu ihrer Herstellung
DK316589A (da) Substituerede azacyclohexylderivater af rifamyciner
DE69119714T2 (de) Verfahren zur Herstellung von Benzylphthalazinonderivaten und von deren Salzen
ATE20063T1 (de) 3-pyridyl-5-alkoxy(oder phenoxy- oder aralkyloxy- )pyrazol-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE2521T1 (de) Verfahren zur herstellung von 2,3-dioxo-1,4benzoxazinderivaten.
DE69232406D1 (de) Verfahren zur Herstellung von Fluoro-Chinolin-3-Carbonsäurederivate
ATE96803T1 (de) Indolo(3,2,1-de>(1,4>-oxazino(2,3,4ij>(1,5>naphthyridinderivate, verfahren zu ihrer herstellung und zwischenprodukte, ihre verwendung als arzneimittel und diese enthaltende zubereitungen.
ES2059451T3 (es) Derivados de naftotiazepina y su procedimiento de preparacion.
ES515201A0 (es) "procedimiento para la fabricacion de derivados n- susbtituidos de la tetrahidroisftalimida".
ATE67194T1 (de) Thiadiazolylacetamid-derivate, verfahren zu ihrer herstellung und ihre verwendung.
DE69127238T2 (de) Verfahren zur Herstellung von Pyrido[1,2-a]pyrimidinderivaten
DK284080A (da) Fremgangsmaade til fremstilling af clavulansyrederivater
MC1555A1 (fr) Dérivés de l'acridanone
DE3782229T2 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee